Clinical Trials Logo

Home Care clinical trials

View clinical trials related to Home Care.

Filter by:
  • None
  • Page 1

NCT ID: NCT05919355 Active, not recruiting - Quality of Life Clinical Trials

Effectiveness of a Communication Device in Home Care Services in Norway: Does Komp Make Older Adults Feel Happier, Safer and More Connected, and Able to Live Longer at Home.

BoVEL
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This study is a field trial where "Komp" is implemented and tested as part of Oslo Municipality's home care services for older adults. Komp is a "one button" communication device designed specifically for older adults who are unfamiliar with or struggle to use conventional digital technologies such as smart phones, computers, or tablets. The aim of the trial is to study the effects of increased social contact with family and care services via Komp. In a randomized design, 300 Komp units will be offered to a sample of older municipal home care service recipients. By comparing the intervention group (who are offered to test Komp for free) with the control group (who receive services as usual), the study will uncover if, on average, users of Komp 1) can live longer at home than non-users, 2) have lesser need of home care services, and 3) are happier, safer, and more socially connected.

NCT ID: NCT05438056 Not yet recruiting - Education Clinical Trials

The Effect of the Mobile Application Developed for Home Care of Preterm

Start date: December 16, 2022
Phase: N/A
Study type: Interventional

mobile application will be developed to support the post-discharge home care of mothers of premature babies. With the developed mobile application, the effect of the education given to the mothers on the knowledge and skills of infant care, mother-infant attachment, and the mother's self-efficacy will be evaluated.

NCT ID: NCT05360797 Not yet recruiting - Acute Pancreatitis Clinical Trials

Acute PAncreatitis and Home Care vs. Hospital Admission Study

PADI_2
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Acute pancreatitis (AP) is one of the most common reason for hospitalization among gastrointestinal diseases in U.S.. The costs caused by severe AP are higher than mild AP. Nevertheless, approximately 70% of hospital admissions for AP are mild cases, if health cost saving is to be realized, it would be by lowering the cost of managing patients with mild AP without affecting patient's safety and satisfaction. With the PADI-1 study, where it was possible to confirm the benefits of an early diet, the rapid recovery of patients with mild AP and the reduction of hospital costs, now a new scope is to be given in the treatment of patients with this pathology. Considering the application of predictive factors of AP severity, and being sure of diagnosing mild AP, a study of home care versus hospitalization for patients with mild AP is proposed. Based on the hypothesis that outpatient care of mild AP patients would be as sage and affective as hospitalization, the aim this study is to campare the results of 3 different strategies of treatment of patients with AP mild. Additionally, satisfaction patient and costs will be analyzed.

NCT ID: NCT03461315 Not yet recruiting - Home Care Clinical Trials

Comparative Study Between Two Models of Home Care.

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Home care is the assistance provided at home to those who can not travel to their Health Center. There are multiple studies on models of home care and many discrepancies about the impact that preventive home visits can have. Hypothesis: home care is expected to be better if performed by a team dedicated exclusively to the home patient, than to the traditional model, where the patient is assisted by the team that cares for the rest of the community. Goals: Main: determine the difference in median cumulative days of hospital admission in 12 months. Secondaries: - results in health - in health experience in efficiency Methodology: Quasi-experimental study of two years duration. All the subjects included in the Home Care Program and that meet the inclusion and exclusion criteria are studied. The care team will provide the informed consent and information sheet to the patient and clinical scales at the beginning and end of the study. Researchers will be responsible for the collection of data that they will anonymize and guard. Statistical analysis: The analyzes will be calculated with the statistical package SPSS version 21 Expected results: hospital admissions (25%) and cumulative days by admission and patient by 65% are expected to improve in the model under study. Applicability and relevance: the trend towards a greater aging of the population makes it necessary to study models of care that allow us to detect which can be beneficial to the population and feasible in our current context.

NCT ID: NCT02658604 Completed - Clinical trials for Medication Therapy Management

Home Medication Reviews by Pharmacists in Ontario, Canada

Start date: January 2016
Phase: N/A
Study type: Observational

RATIONALE: Several examples in the literature describe the types of medication management issues uncovered during the course of home-based medication reviews. For example, the investigators previously reported the outcomes of home medication reviews of 43 homebound community pharmacy patients, finding that 58% of patients were keeping medications in the home that were expired, duplicates of other current medications, or no longer therapeutically appropriate. Many of these issues, due to their nature, could be considered to be "hidden", i.e. issues that are unlikely to be adequately detected or resolved during the course of routine interactions between patients and pharmacists in the community pharmacy setting. Currently, only homebound patients in Ontario are eligible to receive government-funded home medication review services from pharmacists. This limitation in funding eligibility is problematic as it reduces the likelihood that non-homebound patients will receive home medication reviews, even though this population may also benefit from these services. Indeed, evidence in the literature is not limited exclusively to homebound patients, and suggests that non-homebound patients are also at risk from home-centered medication management issues and may also benefit from home medication reviews. PURPOSE: Our study aims to characterize the prevalence and nature of "hidden in the home" medication management issues in non-homebound patients. To our knowledge, this study would be the first of its kind to focus specifically on this patient population and lend direct evidence in support of expanding funding of home medication review services in Ontario to include non-homebound patients. HYPOTHESIS: A subset of ambulatory, non-homebound patients who regularly attend community pharmacies are affected by medication management issues that cannot be adequately identified and resolved during the course of a typical medication review taking place within the pharmacy. These patients would benefit from a full medication review taking place in their own homes, similar to what is presently provided under Ontario's MedsCheck at Home program, for which only homebound patients in Ontario are eligible. RESEARCH QUESTIONS/OBJECTIVES: 1. What is the frequency of, and what type(s) and severity of, drug-related problems are detected during pharmacist visits to patients' homes who would not otherwise qualify for a MedsCheck at Home service? 2. Based on the findings from this study, which criteria would best assist community pharmacists in identifying ambulatory patients who may stand to benefit most from a home-based medication review?

NCT ID: NCT02599246 Completed - COPD Clinical Trials

FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV

NIVLEAKS
Start date: November 17, 2015
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to compare pharyngeal FiO2 in day time with nasal normobaric O2 with inhaled FiO2 in the night time with home care ventilator NIV at the same O2 flow.